Articles
Novel Plasma Proteomic Markers and Risk of Venous Thromboembolism
Venous thromboembolism (VTE), encompassing deep venous thrombosis (DVT) and pulmonary embolism (PE), is a common condition and the third most common life-threatening cardiovascular disease (CVD).
Venous thromboembolism (VTE) is a leading cardiovascular disease, yet its aetiology is incompletely understood. This study used large-scale, high-throughput aptamer-based proteomics to identify new circulating protein biomarkers and biological pathways for incident VTE.
Click here to access the article.